Monica Facco

Padova, 35129, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications

Gene Expression, Non-Coding RNA, and Circular RNA Alterations in Patients with T-Prolymphocytic Leukemia.

Gene Expression, Non-Coding RNA, and Circular RNA Alterations in Patients with T-Prolymphocytic Leukemia.

Journal: Cancers
Published: June 24, 2026

Focal adhesion kinase FAK interplays with ROR1 in the aggressiveness of chronic lymphocytic leukemia.

Focal adhesion kinase FAK interplays with ROR1 in the aggressiveness of chronic lymphocytic leukemia.

Journal: BMC medicine
Published: March 24, 2026

Outcomes of patients with CLL and borderline IGHV mutational status: a systematic review and meta analysis.

Outcomes of patients with CLL and borderline IGHV mutational status: a systematic review and meta analysis.

Journal: Biomarker research
Published: January 13, 2026

Transcriptomic landscape of CD8+ and CD4 + T-LGL leukemia revealed the distinct impact of STAT3 and STAT5B activating mutations.

Transcriptomic landscape of CD8+ and CD4 + T-LGL leukemia revealed the distinct impact of STAT3 and STAT5B activating mutations.

Journal: Leukemia
Published: March 02, 2025

Proteasome Inhibitors Induce Apoptosis in Ex Vivo Cells of T-Cell Prolymphocytic Leukemia.

Proteasome Inhibitors Induce Apoptosis in Ex Vivo Cells of T-Cell Prolymphocytic Leukemia.

Journal: International journal of molecular sciences
Published: November 12, 2024

Case report: Breaking CNS immuno-privilege: TNFα-inhibitor triggers aseptic meningitis in a patient with rheumatoid arthritis.

Case report: Breaking CNS immuno-privilege: TNFα-inhibitor triggers aseptic meningitis in a patient with rheumatoid arthritis.

Journal: Frontiers in immunology
Published: May 13, 2024

Protein kinase CK2α is overexpressed in classical hodgkin lymphoma, regulates key signaling pathways, PD-L1 and may represent a new target for therapy.

Protein kinase CK2α is overexpressed in classical hodgkin lymphoma, regulates key signaling pathways, PD-L1 and may represent a new target for therapy.

Journal: Frontiers in immunology
Published: February 29, 2024

Chronic Lymphocytic Leukemia (CLL) with Borderline Immunoglobulin Heavy Chain Mutational Status, a Rare Subgroup of CLL with Variable Disease Course.

Chronic Lymphocytic Leukemia (CLL) with Borderline Immunoglobulin Heavy Chain Mutational Status, a Rare Subgroup of CLL with Variable Disease Course.

Journal: Cancers
Published: January 24, 2024

The added value of karyotype in predicting the need for therapy in chronic lymphocytic leukemia with 13q deletion.

The added value of karyotype in predicting the need for therapy in chronic lymphocytic leukemia with 13q deletion.

Journal: Hematological oncology
Published: July 04, 2023

Focal adhesion kinase activation by calcium-dependent calpain is involved in chronic lymphocytic leukaemia cell aggressiveness.

Focal adhesion kinase activation by calcium-dependent calpain is involved in chronic lymphocytic leukaemia cell aggressiveness.

Journal: British journal of haematology
Published: April 11, 2023

Is It Still Possible to Think about HSP70 as a Therapeutic Target in Onco-Hematological Diseases?

Is It Still Possible to Think about HSP70 as a Therapeutic Target in Onco-Hematological Diseases?

Journal: Biomolecules
Published: February 02, 2023

Pro-inflammatory cells sustain leukemic clonal expansion in T-cell large granular lymphocyte leukemia.

Pro-inflammatory cells sustain leukemic clonal expansion in T-cell large granular lymphocyte leukemia.

Journal: Haematologica
Published: November 18, 2022
Showing 1-12 of 63

Last Updated: 09/26/2026